Trials

Anti-cancer drug shows incredible promise in phase 1 human clinical trials

A clinical trial of PAC-1, a drug that spurs programmed cell death in cancer cells, found only minor side effects in patients with cancers.

Groundbreaking cancer drug developed by Stanford researchers Joseph Shavit

Groundbreaking study finds monoclonal antibodies can prevent Malaria Joseph Shavit

World First: Scientists just injected a human with a cancer-killing virus Joseph Shavit